Resveratrol reduces IL-6 and VEGF secretion from co-cultured A549 lung cancer cells and adipose-derived mesenchymal stem cells
出版年份 2015 全文链接
标题
Resveratrol reduces IL-6 and VEGF secretion from co-cultured A549 lung cancer cells and adipose-derived mesenchymal stem cells
作者
关键词
Mesenchymal stem cells, Cancer cells, A549, IL-6, VEGF and resveratrol
出版物
TUMOR BIOLOGY
Volume 37, Issue 6, Pages 7573-7582
出版商
Springer Nature
发表日期
2015-12-19
DOI
10.1007/s13277-015-4643-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells
- (2015) Norashikin Zakaria et al. BMC CANCER
- Paracrine factors from adipose-mesenchymal stem cells enhance metastatic capacity through Wnt signaling pathway in a colon cancer cell co-culture model
- (2015) Dongmei Chen et al. Cancer Cell International
- Stem Cell Therapies in Clinical Trials: Progress and Challenges
- (2015) Alan Trounson et al. Cell Stem Cell
- Anti-inflammatory effect of resveratrol in old mice liver
- (2015) Bui Thanh Tung et al. EXPERIMENTAL GERONTOLOGY
- Effects of Resveratrol on the Treatment of Inflammatory Response Induced by Severe Burn
- (2015) Ke Tao et al. INFLAMMATION
- IL-6 originated from breast cancer tissue-derived mesenchymal stromal cells may contribute to carcinogenesis
- (2015) Özlem Sağlam et al. TUMOR BIOLOGY
- Human adipose-derived mesenchymal stem cells repair cisplatin-induced acute kidney injury through antiapoptotic pathways
- (2015) WEIQI YAO et al. Experimental and Therapeutic Medicine
- Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts
- (2015) Ridwana Chowdhury et al. Oncotarget
- Adipose Tissue-Derived Stem Cells Differentiate into Carcinoma-Associated Fibroblast-Like Cells under the Influence of Tumor-Derived Factors
- (2015) Constantin Jotzu et al. Analytical Cellular Pathology
- Resveratrol Synergistically Triggers Apoptotic Cell Death with Arsenic Trioxide via Oxidative Stress in Human Lung Adenocarcinoma A549 Cells
- (2014) Shiyan Gu et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- International trends in lung cancer incidence by histological subtype: Adenocarcinoma stabilizing in men but still increasing in women
- (2014) J. Lortet-Tieulent et al. LUNG CANCER
- Resveratrol induces human K562 cell apoptosis, erythroid differentiation, and autophagy
- (2014) Hui-Wen Yan et al. TUMOR BIOLOGY
- Mesenchymal stem cells: a new trend for cell therapy
- (2013) Xin Wei et al. ACTA PHARMACOLOGICA SINICA
- Human Mesenchymal Stem Cells Promote Cancer Motility and Cytokine Secretion in vitro
- (2013) A. Scherzed et al. CELLS TISSUES ORGANS
- Inhibitory effect and mechanism of mesenchymal stem cells on liver cancer cells
- (2013) Lingling Hou et al. TUMOR BIOLOGY
- Mesenchymal stem cell signaling in cancer progression
- (2012) Anja Torsvik et al. CANCER TREATMENT REVIEWS
- Clinical applications of mesenchymal stem cells
- (2012) Shihua Wang et al. Journal of Hematology & Oncology
- Resveratrol Exerts Dosage and Duration Dependent Effect on Human Mesenchymal Stem Cell Development
- (2012) Lindsay Peltz et al. PLoS One
- Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks
- (2011) Suling Liu et al. CANCER RESEARCH
- Ischemic insult induced apoptotic changes in PC12 cells: Protection by trans resveratrol
- (2011) Megha Agrawal et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway
- (2011) Han-Shui Hsu et al. LUNG CANCER
- The bad and the good of mesenchymal stem cells in cancer: Boosters of tumor growth and vehicles for targeted delivery of anticancer agents
- (2010) Umberto Galderisi World Journal of Stem Cells
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More